Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections

Invasive fungal infections (IFIs) are associated with high mortality rates and timely appropriate antifungal therapy is essential for good outcomes. Emerging antifungal resistance among <i>Candida</i> and <i>Aspergillus</i> spp., the major causes of IFI, is concerning and has...

Full description

Bibliographic Details
Published in:	Journal of Fungi
Main Authors:	Frederic Lamoth, Russell E. Lewis, Dimitrios P. Kontoyiannis
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Subjects:	invasive aspergillosis invasive candidiasis mucormycosis clinical breakpoints minimal inhibitory concentration therapeutic response
Online Access:	https://www.mdpi.com/2309-608X/7/1/17

Similar Items

Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study
by: Yubhisha Dabas, et al.
Published: (2021-12-01)

Invasive fungal infections and the management in immunocompromised conditions
by: Garima Anandani, et al.
Published: (2025-07-01)

Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
by: Tingting Zhang, et al.
Published: (2022-12-01)

The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches
by: Zoe Freeman Weiss, et al.
Published: (2021-02-01)

Invasive Fungal Infections Associated with COVID-19
by: Kyaw M. Hlaing, et al.
Published: (2023-06-01)

Post-COVID-19 Fungal Infection in the Aged Population
by: Vivek P. Chavda, et al.
Published: (2023-02-01)

An Overview of the Management of the Most Important Invasive Fungal Infections in Patients with Blood Malignancies
by: Shariati A, et al.
Published: (2020-07-01)

2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan
by: Hsiang-Chi Kung, et al.
Published: (2018-02-01)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
by: Sebastian Wurster, et al.
Published: (2022-10-01)

Antifungal Susceptibility and Genotypic Analysis of cyp51A Mutations in Aspergillus fumigatus Isolates in Malaysia
by: Tan XT, et al.
Published: (2024-05-01)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
by: Angel León-Buitimea, et al.
Published: (2021-10-01)

Systemic Antifungal Therapy for Invasive Pulmonary Infections
by: Ronen Ben-Ami
Published: (2023-01-01)

CT imaging findings of invasive pulmonary fungal infections in hemato-oncologic children
by: Leonor Alamo, et al.
Published: (2024-12-01)

The Changing Landscape of Invasive Fungal Infections in ICUs: A Need for Risk Stratification to Better Target Antifungal Drugs and the Threat of Resistance
by: Julien Poissy, et al.
Published: (2022-09-01)

Determination of resistance Candida spp. to antifungal agents with systemic action epsilometric method (E-test) with the species-specific characteristics of Candida
by: N. S. Bagirova, et al.
Published: (2015-11-01)

The rising burden of invasive fungal infections in COVID-19, can structured CT thorax change the game
by: Roopak Dubey, et al.
Published: (2022-01-01)

Mixed invasive fungal infections among COVID-19 patients
by: Vanya Singh, et al.
Published: (2021-12-01)

Invasive fungal infections in a pediatric hematology-oncology department: A 16-year retrospective study
by: Nikoleta Kazakou, et al.
Published: (2020-06-01)

Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs
by: Kam Lun Ellis Hon, et al.
Published: (2024-06-01)

Mapping the Burden of Fungal Diseases in the United Arab Emirates
by: Fatima Al Dhaheri, et al.
Published: (2024-05-01)

Expert group opinion for diagnosis and management of fungal infections in solid organ transplant recipients in South Asia
by: Rajeev Soman, et al.
Published: (2022-01-01)

Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review
by: Afzal Azim, et al.
Published: (2024-03-01)

Fungal Infection in Upper Gastrointestinal Tract
by: Ayoung Lee, et al.
Published: (2024-06-01)

Epidemiology and burden of invasive fungal infections in the countries of the Arab League
by: Joumana Kmeid, et al.
Published: (2020-12-01)

Evaluations of Antifungal Susceptibilities Have to Be According to Reference Guidelines: CLSI and EUCAST
by: Ali Korhan Sığ
Published: (2022-01-01)

Invasive fungal infection: a visible menace
by: Priti Dave, et al.
Published: (2024-05-01)

Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study
by: Katherine Stull, et al.
Published: (2019-10-01)

Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis
by: Chun-Yu Lin, et al.
Published: (2019-11-01)

Estimation of Serum Levels of Heavy Metals in Patients with Chronic Invasive Fungal Rhinosinusitis Before the COVID-19 Era: A Pilot Study
by: Smile Kajal, et al.
Published: (2022-03-01)

Invasive Fungal Infections Complicating COVID-19: A Narrative Review
by: Giacomo Casalini, et al.
Published: (2021-10-01)

Benefits of early antifungal therapy in hematology patients
by: S. S. Andreev, et al.
Published: (2024-01-01)

Mortality Rate and Predictive Factors for Invasive Fungal Rhinosinusitis: Experience in Siriraj Hospital
by: Premyot Ngaotepprutaram, et al.
Published: (2018-03-01)

Predisposing factors of mycotic infections in COVID-19 patients
by: Satyam Singh, et al.
Published: (2022-01-01)

Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade
by: Souha S. Kanj, et al.
Published: (2022-10-01)

Opportunistic Fungal Invasion in COVID-19 Pandemic: A Critical Review in Diagnosis and Management
by: Abhishek Sharma, et al.
Published: (2023-07-01)

Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
by: Egger M, et al.
Published: (2023-04-01)

A review on fungal surgical site infections: epidemiology, risk factors, main fungal agents, and prevention
by: Kiana Shirani, et al.
Published: (2025-07-01)

Ibrexafungerp: A narrative overview
by: L'Emir Wassim El Ayoubi, et al.
Published: (2024-01-01)

Clinicopathological analysis of fungal lesions with unique presentations in immunocompetent adults – A case series from a tertiary care hospital in North Karnataka
by: Meenakshi Masgal, et al.
Published: (2021-01-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)